Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions

Mostrar otras versiones (2)

Many drugs that have been proposed for treatment of coronavirus disease 2019 (COVID‐19) are reported to cause cardiac adverse events, including ventricular arrhythmias. In order to properly weigh risks against potential benefits, particularly when decisions must be made quickly, mathematical modelin...

Descripción completa

Detalles Bibliográficos
Autores principales: Varshneya, Meera, Irurzun-Arana, Itziar, Campana, Chiara, Dariolli, Rafael, Gutierrez, Amy, Pullinger, Taylor K., Sobie, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753424/
https://www.ncbi.nlm.nih.gov/pubmed/33205613
http://dx.doi.org/10.1002/psp4.12573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753424/
https://www.ncbi.nlm.nih.gov/pubmed/33205613
http://dx.doi.org/10.1002/psp4.12573

Ejemplares similares